The Trump administration’s turbulent healthcare stewardship claimed another scalp with the departure of the 27th FDA Commissioner Dr. Marty Makary last month after 13 months in the role. He left
Peterson Philanthropies Unveils Employer Health Analytics Company via $50M Commitment
Peterson Philanthropies on Tuesday launched Peterson Health Analytics, a public-benefit analytics company for employers, backed by a $50 million commitment. Peterson Philanthropies is a network of nonprofit organizations focused on
Former FDA Officials: There’s Opportunity to Rebuild the Agency — But Not the Way It Was
The operational structure of the FDA around centers, each governing a particular regulatory or scientific area, dates back more than 40 years. It remains intact for now, but Rick Pazdur,
New Technology is Revolutionizing Clinical Trial Data Management — Here’s How Research Hospitals Can Seize the Moment
We continue to see enormous technological and scientific progress in the area of drug discovery, with the promise of AI to upend traditional models and approaches becoming more fully realized
Novellia Snags $18M for Its Real-World Data Platform
On Tuesday, a startup challenging the traditional real-world data industry announced the close of its Series A funding round. New York-based Novellia raised $18 million, bringing its total funding amount
Ilant Health Raises $15M to Advance Obesity Care
Ilant Health, an obesity care company for employers and health plans, announced Tuesday that it secured $15 million in Series A funding. New York City-based Ilant Health is a value-based
What Data Delays Are Costing Healthcare — And Its Patients
Healthcare organizations use data to guide care, manage benefits and understand how members use services. Yet most of healthcare still works with information that arrives too late to be useful.
Massachusetts Attorney General Sues UnitedHealthcare, Alleges $100M MassHealth Fraud
Massachusetts Attorney General Andrea Joy Campbell sued UnitedHealthcare on Friday, alleging the insurer “falsely manipulated” the health status of MassHealth members enrolled in the Senior Care Options plan in order
Servier Moves Into Muscular Dystrophy, Paying $1.5B for Assets From Edgewise Therapeutics
Servier is expanding its scope in neurology to include neuromuscular disorders by acquiring a clinical-stage Edgewise Therapeutics drug that offers a novel approach to treating two rare neuromuscular disorders. Per
Are We Measuring Metabolic Health All Wrong?
Modern medicine has made remarkable advances in treating metabolic disease. We have more effective medications, better clinical guidelines, and a deeper understanding of the interplay between obesity, diabetes, cardiovascular disease,









